These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38477025)

  • 1. Multispecies comparative prostate anatomy by imaging: Implications for experimental models of prostatic disease.
    Berg FM; Correia ETO; Abenojar EC; Basilion JP; Rosol TJ; Baroni RH; Exner AA; Bittencourt LK
    Prostate; 2024 May; 84(7):682-693. PubMed ID: 38477025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit.
    Wang Y; Abenojar EC; Wang J; de Leon AC; Tavri S; Wang X; Gopalakrishnan R; Walker E; MacLennan GT; Giles A; Czarnota GJ; Basilion JP; Exner AA
    Prostate; 2022 May; 82(6):695-705. PubMed ID: 35167141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated segmentation of prostate zonal anatomy on T2-weighted (T2W) and apparent diffusion coefficient (ADC) map MR images using U-Nets.
    Zabihollahy F; Schieda N; Krishna Jeyaraj S; Ukwatta E
    Med Phys; 2019 Jul; 46(7):3078-3090. PubMed ID: 31002381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2 Mapping in Prostate Cancer.
    Mai J; Abubrig M; Lehmann T; Hilbert T; Weiland E; Grimm MO; Teichgräber U; Franiel T
    Invest Radiol; 2019 Mar; 54(3):146-152. PubMed ID: 30394962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Imaging Detection of Glucose-Stimulated Zinc Secretion in the Enlarged Dog Prostate as a Potential Method for Differentiating Prostate Cancer From Benign Prostatic Hyperplasia.
    Khalighinejad P; Parrott D; Jordan VC; Chirayil S; Preihs C; Rofsky NM; Xi Y; Sherry AD
    Invest Radiol; 2021 Jul; 56(7):450-457. PubMed ID: 34086013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostatic hyperplasia after prostatic arterial embolization in a canine model: A 3T multiparametric MRI and whole-mount step-section pathology correlated longitudinal study.
    Li B; Xu A; Wang N; Min X; Feng Z; Deng M; Li L; Cai J; Kang Z; Jiang K; Kuang D; Wang L
    J Magn Reson Imaging; 2017 Oct; 46(4):1220-1229. PubMed ID: 28182304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully automated detection of prostate transition zone tumors on T2-weighted and apparent diffusion coefficient (ADC) map MR images using U-Net ensemble.
    Wong T; Schieda N; Sathiadoss P; Haroon M; Abreu-Gomez J; Ukwatta E
    Med Phys; 2021 Nov; 48(11):6889-6900. PubMed ID: 34418108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central zone lesions on magnetic resonance imaging: Should we be concerned?
    Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
    Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
    Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-guided, transrectal, intraprostatic steam application as potential focal therapeutic modality for prostatic diseases in a large animal translational model: A feasibility follow-up study.
    Wang-Leandro A; Willmitzer F; Karol A; Porcellini B; Kronen P; Hiltbrand EM; Rüfenacht D; Kircher PR; Richter H
    PLoS One; 2019; 14(12):e0226764. PubMed ID: 31869376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted and perfusion-weighted magnetic resonance imaging of the prostate gland of healthy adult dogs.
    Willmitzer F; Del Chicca F; Kircher PR; Wang-Leandro A; Kronen PW; Verdino D; Rüfenacht D; Porcellini B; Richter H
    Am J Vet Res; 2019 Sep; 80(9):832-839. PubMed ID: 31449441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3.0 T prostate MRI: Visual assessment of 2D and 3D T2-weighted imaging sequences using PI-QUAL score.
    Brillat-Savarin N; Wu C; Aupin L; Thoumin C; Hamzaoui D; Renard-Penna R
    Eur J Radiol; 2023 Sep; 166():110974. PubMed ID: 37453273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Everyman's prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy.
    Mueller-Lisse UG; Murer S; Mueller-Lisse UL; Kuhn M; Scheidler J; Scherr M
    Eur Radiol; 2017 Aug; 27(8):3362-3371. PubMed ID: 28058480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting prostate cancer and prostatic calcifications using advanced magnetic resonance imaging.
    Dou S; Bai Y; Shandil A; Ding D; Shi D; Haacke EM; Wang M
    Asian J Androl; 2017; 19(4):439-443. PubMed ID: 27004542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
    J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.
    Fedorov A; Vangel MG; Tempany CM; Fennessy FM
    Invest Radiol; 2017 Sep; 52(9):538-546. PubMed ID: 28463931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance and reproducibility of T2w based and diffusion weighted imaging (DWI) based PI-RADSv2 lexicon descriptors for prostate MRI.
    Benndorf M; Hahn F; Krönig M; Jilg CA; Krauss T; Langer M; Dovi-Akué P
    Eur J Radiol; 2017 Aug; 93():9-15. PubMed ID: 28668436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing structure of normal and malignant prostate tissue before and after radiation therapy with luminal water fraction and diffusion-weighted MRI.
    Carlin D; Orton MR; Collins D; deSouza NM
    J Magn Reson Imaging; 2019 Aug; 50(2):619-627. PubMed ID: 30589150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
    Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
    Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.